Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncology Report

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2013.2325PMID 23467769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small RNAs Targeting Transcription Start Site Induce Heparanase Silencing through Interference with Transcription Initiation in Human Cancer Cells

  2012cited by this paper
• The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

  2012cited by this paper
• Prognostic value of heparanase expression and cellular localization in oral cancer

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells

  2010cited by this paper
• Heparanase expression of glioma in human and animal models.

  2010cited by this paper
• Clinical relevance of heparanase mRNA expression in bladder cancer and its usefulness as a detection marker in voided urine.

  2009cited by this paper
• Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression

  2009cited by this paper
• Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy

  2008cited by this paper
• Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.

  2007cited by this paper
• Mammalian heparanase: what is the message?

  2007cited by this paper
• Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo

  2007cited by this paper
• Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.

  2007cited by this paper
• Elevated serum heparanase‐1 levels in patients with pancreatic carcinoma are associated with poor survival

  2006cited by this paper
• Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival

  2006cited by this paper
• Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

  2006cited by this paper
• Development of heparanase inhibitors for anti-cancer therapy.

  2006cited by this paper
• Nasopharyngeal carcinoma.

  2005cited by this paper
• Heparanase expression correlates with malignant potential in human colon cancer

  2005cited by this paper
• Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).

  2005cited by this paper
• [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features].

  2004cited by this paper
• Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

  2004cited by this paper
• Heparanase as a molecular target of cancer chemotherapy

  2004cited by this paper
• Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

  2004cited by this paper
• High heparanase activity in multiple myeloma is associated with elevated microvessel density.

  2003cited by this paper
• Heparanase expression in human leukemias is restricted to acute myeloid leukemias.

  2002cited by this paper
• RNA interference: mechanisms and applications.

  2001cited by this paper
• Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

  1999cited by this paper
• Suramin. A potent inhibitor of melanoma heparanase and invasion.

  1991cited by this paper
• Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.

  1983cited by this paper
• Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

  1983cited by this paper
• Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma.

  1975cited by this paper
• Nasopharyngeal Carcinoma

  1966cited by this paper

• LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells

  2019cites this paper
• Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway

  2018cites this paper
• Heparanase confers a growth advantage to differentiating murine embryonic stem cells, and enhances oligodendrocyte formation.

  2017cites this paper
• Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus

  2016cites this paper
• HPSE expression correlates with invasive behaviors in lung cancer

  2016cites this paper
• Mechanisms of Invasion in Head and Neck Cancer.

  2015cites this paper
• Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase.

  2015cites this paper
• Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen following Diabetes

  2014cites this paper
• Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen After Diabetes

  2014cites this paper